title: Low-dose tissue plasminogen activator in pulmonary embolism: benefit remains unclear.
authors.affiliation: Department of Medicine, Tulane University, Stanford, CA. Electronic address: shigekis@stanford.edu.
authors.forename: Shigeki
authors.initials: S
authors.lastname: Saito
authors.affiliation: Stanford University; and the Department of Medicine, Tulane University, New Orleans, LA.
authors.forename: Basal
authors.initials: B
authors.lastname: Altaqi
authors.affiliation: Stanford University; and the Department of Medicine, Tulane University, New Orleans, LA.
authors.forename: Francesco
authors.initials: F
authors.lastname: Simeone
mesh_terms: D000208:Acute Disease; D000792:Angiography; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator